- 全部删除
您的购物车当前为空
DBPR108是新型、具有口服活性、选择性的DPP4抑制剂,IC50=为15nM,对DPP8和DPP9基本无抑制。


为众多的药物研发团队赋能,
让新药发现更简单!
DBPR108是新型、具有口服活性、选择性的DPP4抑制剂,IC50=为15nM,对DPP8和DPP9基本无抑制。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 286 | In stock | |
| 5 mg | ¥ 713 | In stock | |
| 10 mg | ¥ 1,150 | In stock | |
| 25 mg | ¥ 1,990 | In stock | |
| 50 mg | ¥ 2,830 | In stock | |
| 100 mg | ¥ 3,810 | In stock | |
| 200 mg | ¥ 5,220 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 688 | In stock |
DBPR108 相关产品
| 产品描述 | DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9. |
| 体外活性 | DBPR108 在DPP8、DPP9、FAP和DPP-II上展现出超过3000倍的选择性。 |
| 体内活性 | DBPR108作为2型糖尿病潜在化合物,是一种强效、选择性、长效且安全的DPP-IV抑制剂。其体内效果,包括抑制血浆DPP-IV活性和抑制血糖升高,也得到了证明。 |
| 分子量 | 324.39 |
| 分子式 | C16H25FN4O2 |
| CAS No. | 1186426-66-3 |
| Smiles | CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N |
| 密度 | 1.20 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: ≥ 25 mg/mL (77.07 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容